IMPACT OF ADMINISTRATION-RELATED FACTORS ON OUTCOME OF ADJUVANT CHEMOTHERAPY FOR PRIMARY BREAST-CANCER

被引:45
作者
PRONZATO, P
CAMPORA, E
AMOROSO, D
BERTELLI, G
BOTTO, F
CONTE, PF
SERTOLI, MR
ROSSO, R
机构
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1989年 / 12卷 / 06期
关键词
D O I
10.1097/00000421-198912000-00004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:481 / 485
页数:5
相关论文
共 15 条
[1]   COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER [J].
BONADONNA, G ;
BRUSAMOLINO, E ;
VALAGUSSA, P ;
ROSSI, A ;
BRUGNATELLI, L ;
BRAMBILLA, C ;
DELENA, M ;
TANCINI, G ;
BAJETTA, E ;
MUSUMECI, R ;
VERONESI, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) :405-410
[2]   DOSE-RESPONSE EFFECT OF ADJUVANT CHEMOTHERAPY IN BREAST-CANCER [J].
BONADONNA, G ;
VALAGUSSA, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (01) :10-15
[3]  
BONADONNA G, 1986, NATL CANCER I MONOGR, V1, P45
[4]  
BONADONNA G, 1987, ADJUVANT THERAPY CAN, V5, P211
[5]  
BROOKS RJ, 1983, P AN M AM SOC CLIN, V2, P110
[6]  
COPPIN CML, 1987, SEMIN ONCOL, V14, P34
[7]  
COX DR, 1972, J R STAT SOC B, V34, P187
[8]  
ENGELSMAN E, 1987, COMPARISON CLASSICAL
[9]  
FISHER B, 1983, CANCER RES, V43, P1488
[10]   1-PHENYLALANINE MUSTARD (L-PAM) IN MANAGEMENT OF PRIMARY BREAST-CANCER - REPORT OF EARLY FINDINGS [J].
FISHER, B ;
CARBONE, P ;
ECONOMOU, SG ;
FRELICK, R ;
GLASS, A ;
LERNER, H ;
REDMOND, C ;
ZELEN, M ;
BAND, P ;
KATRYCH, DL ;
WOLMARK, N ;
FISHER, ER .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (03) :117-122